MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting

    K. Markopoulou, A. Premkumar, B. Schoneburg, S. Walters, R. Frigerio, M. Szela, D.M. Maraganore (Glenview, IL, USA)

    Objective: To assess the temporal profile of motor and non-motor symptoms in Parkinson's disease. Background: Parkinson's disease is characterized by varying combinations of motor and…
  • 2016 International Congress

    Multicenter report of clinical use of a non-motor symptom questionnaire for craniocervical dystonia: The DNMS quest

    L. Klingelhoefer, M. Kaiser, D. Martino, L. Perkins, M. Wienecke, A. Sauerbier, R. Untucht, D. Trivedi, K. Mammadova, T. Chiwera, A. Rizos, P. Martinez-Martin, H. Reichmann, K.R. Chaudhuri (Dresden, Germany)

    Objective: To validate a non motor symptom (NMS) questionnaire in patients with craniocervical dystonia (CCD). Background: We have reported the clinical use of a Dystonia…
  • 2016 International Congress

    The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale

    L.S. Croll, K.M. Montgomery, C.V. Kulick, M.J. Nirenberg (New York, NY, USA)

    Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…
  • 2016 International Congress

    Dosing of abobotulinumtoxinA and muscle selection in patients with simple patterns of cervical dystonia

    V.P. Misra, R. Trosch, S. Om, P. Maisonobe (London, United Kingdom)

    Objective: To report international dosing practice for abobotulinumtoxinA (ABO) in a real-world pragmatic setting for the management of cervical dystonia (CD) with simple patterns. Background:…
  • 2016 International Congress

    Categories of psychogenic movement disorders to functional blepharospasm

    J. Gazulla (Zaragoza, Spain)

    Objective: 1) To investigate if the categories of psychogenic dystonia (PD) proposed by Gupta and Lang could be applied to psychogenic blepharospasm (PB); 2) To…
  • 2016 International Congress

    Impaired response times to luminance stimuli in dystonia patients indicate disordered superior colliculus processing

    L. Williams, J.S. Butler, B. Quinlivan, A. Molloy, E. McGovern, I. Beiser, M. Thirkettle, S. O'Riordan, P. Redgrave, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: We hypothesise that patients with adult onset isolated focal dystonia (AOIFD) will have slower reaction times to luminance stimuli versus healthy controls due to…
  • 2016 International Congress

    Gaze evoked blepharospasm

    P.P. Urban (Hamburg, Germany)

    Objective: Herein we present a patient with asymmetric blepharospasm (BLS) evoked by upward gaze. Background: Essential BLS is a focal presentation of dystonia. However, brain…
  • 2016 International Congress

    Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?

    F. Richter, C. Bode, C. Spröte, A. Bauer, A. Richter (Leipzig, Germany)

    Objective: To further define the pathophysiology of the reduction of striatal interneurons in an animal model of dystonia and to develop novel therapeutic strategies targeting…
  • 2016 International Congress

    Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia

    M. Bologna, G. Paparella, A. Fabbrini, G. Leodori, L. Rocchi, M. Hallett, A. Berardelli (Pozzilli, Italy)

    Objective: To investigate the influence of the cerebellum on the motor cortex in primary focal dystonia using cerebellar continuous theta-burst stimulation (cTBS) and to evaluate…
  • 2016 International Congress

    Features of the quality of life and related disorders in patients with focal dystonia

    Z.A. Akbarkhodjaeva, G.S. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: To evaluate the features of the quality of life (QOL) and related disorders in patients with focal dystonia (FD). Background: Studying neuropsychological disorders is…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley